Screening breast cancer patients for Norwegian ATM mutations

被引：9
|
作者：
Laake, K
Vu, P
Andersen, TI
Erikstein, B
Kåresen, R
Lonning, PE
Skovlund, E
Borresen-Dale, AL [1 ]
机构：
[1] Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Dept Oncol, N-0407 Oslo, Norway
[3] Univ Oslo, Ulleval Hosp, Dept Surg, N-0407 Oslo, Norway
[4] Norwegian Radium Hosp, Dept Oncol, N-0310 Oslo, Norway
[5] Norwegian Radium Hosp, Clin Res Off, N-0310 Oslo, Norway
[6] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway
来源：
BRITISH JOURNAL OF CANCER | 2000年 / 83卷 / 12期
关键词：
ataxia telangiectasia; breast neoplasms; heterozygote detection; polymerase chain reaction; breast cancer risk; Norwegian founder mutation;
D O I：
10.1054/bjoc.2000.1519
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
483 Norwegian breast cancer patients were screened for six different ataxia telangiectasia mutated (ATM) mutations previously found to account for 83% of the disease alleles in Norwegian ataxia telangiectasia (AT) patients. Only one carrier was found. These results provide no evidence in favour of an excess risk of breast cancer associated with heterozygosity for classical AT mutations, but remain consistent with a maximum 2.4-fold increased risk. (C) 2000 Cancer Research Campaign.
引用
收藏
页码：1650 / 1653
页数：4
相关论文
共 50 条
  • [31] ATM mutations contribution to hereditary breast-pancreatic cancer
    Gordon, O. K.
    Childers, K.
    McFarland, R.
    Laduca, H.
    CANCER RESEARCH, 2017, 77
  • [32] Clinical Toxicity in Hypofractionated and Conventionally Fractionated Radiation in Breast Cancer Patients with Germline ATM Mutations
    Jan, I.
    Yehia, Z. A.
    Ghaddar, B.
    Neibart, S. S.
    Nie, K.
    Schiff, D. S.
    Khiabanian, H.
    Ganesan, S.
    Toppmeyer, D.
    Haffty, B. G., Jr.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E31 - E31
  • [33] Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients
    Dunst, J
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 (04) : 224 - 225
  • [34] Missense mutations but not allelic variants alter the function of ATM by dominant interference in patients with breast cancer
    Scott, SP
    Bendix, R
    Chen, P
    Clark, R
    Dörk, T
    Lavin, MF
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) : 925 - 930
  • [35] Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients
    Dörk, T
    Bendix, R
    Bremer, M
    Rades, D
    Klöpper, K
    Nicke, M
    Skawran, B
    Hector, A
    Yamini, P
    Steinmann, D
    Weise, S
    Stuhrmann, M
    Karstens, JH
    CANCER RESEARCH, 2001, 61 (20) : 7608 - 7615
  • [36] Challenges in Interpreting Germline Mutations in BARD1 and ATM in Breast and Ovarian Cancer Patients
    DeLeonardis, Kimberly
    Sedgwick, Kristin
    Voznesensky, Olga
    Matloff, Ellen
    Hofstatter, Erin
    Balk, Steven
    Tung, Nadine
    BREAST JOURNAL, 2017, 23 (04): : 461 - 464
  • [37] ATM Genetic Screening in Breast Cancer Families with Haematological Diseases
    La Paglia, L.
    Lauge, A.
    Weber, J.
    Champ, J.
    Cavaciuti, E.
    Viovy, J. L.
    Russo, A.
    Stoppa-Lyonnet, D.
    ONCOLOGY, 2009, 77 : 149 - 150
  • [38] Pre screening breast history in women participating in the prevalent screening round in the Norwegian Breast Cancer Screening Program
    Hofvind, S.
    Ertzaas, A.
    Thoresen, S.
    EJC SUPPLEMENTS, 2004, 2 (03): : 185 - 185
  • [39] Compression forces used in the Norwegian Breast Cancer Screening Program
    Waade, Gunvor G.
    Moshina, Nataliia
    Sebuodegard, Sofie
    Hogg, Peter
    Hofvind, Solveig
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1071):
  • [40] Cost-effectiveness of the Norwegian breast cancer screening program
    van Luijt, P. A.
    Heijnsdijk, E. A. M.
    de Koning, H. J.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 140 (04) : 833 - 840
12345